VISTAGEN THERAPEUTICS, INC. Treasury Stock, Common, Value
VISTAGEN THERAPEUTICS, INC. (VTGN) had Treasury Stock, Common, Value of $3.97 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockCommonValue · last filed 2026-08-14
- 2026-06-30: Treasury Stock, Common, Value $3.97M.
- 2026-03-31: Treasury Stock, Common, Value $3.97M.
- 2025-12-31: Treasury Stock, Common, Value $3.97M.
- 2025-09-30: Treasury Stock, Common, Value $3.97M.
| Period end | Treasury Stock, Common, Value | Treasury Stock, Common, Value as first filed |
|---|---|---|
| 2026-06-30 | $3.97M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $3.97M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $3.97M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $3.97M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $3.97M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $3.97M 10-K · filed 2026-06-15 | |
| 2024-12-31 | $3.97M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $3.97M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $3.97M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $3.97M 10-K · filed 2025-06-17 | |
| 2023-12-31 | $3.97M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $3.97M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $3.97M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $3.97M 10-K · filed 2024-06-11 | $3.97M 10-K · filed 2023-06-28 |
| 2022-03-31 | $3.97M 10-K · filed 2023-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |